• Nenhum resultado encontrado

Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma.

N/A
N/A
Protected

Academic year: 2017

Share "Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma."

Copied!
22
0
0

Texto

Loading

Referências

Documentos relacionados

nidine (CHS 828) and mitoguazone (MGBG) have shown promising antitumor activity in preclinical tumor models, while mitoguazone showed useful clinical activity for the treat- ment

A complexidade do processo de desenvolvimento de aplicações sensíveis ao contexto pode ser minimizada pela utilização de camadas de abstração intermédia, ou sistemas de

Gene transfer strategies include inhibition of pro-inflammatory cytokines, blockade of cartilage-de- grading metalloproteinases, inhibition of synovial cell activation and

It is interesting to stress that, while 19th century monetary unifications did not arise any concern or protests for their economic and financial consequences, the

This is the first report on the isolation and identification of endophytic bacteria from Jacaranda decurrens Cham.. Key words: Endophytic bacteria, Jacaranda decurrens

Figure 2 - Tumor weight and tumor inhibition rate (%) of Sarcoma 180 after 21 days of mice treatment with 10, 30 and 50 mg/kg of FII fraction extracted from mycelial biomass

When EZH2 protein expression was significantly down-regulated by treatment with EZH2 siRNA the signal- ing proteins of the PI3K/Akt/mTOR pathway also showed a significant reduction